Literature DB >> 19539724

Subcellular plasticity of the corticotropin-releasing factor receptor in dendrites of the mouse bed nucleus of the stria terminalis following chronic opiate exposure.

A Jaferi1, D A Lane, V M Pickel.   

Abstract

Chronic opiate administration alters the expression levels of the stress-responsive peptide, corticotropin-releasing factor (CRF), in the bed nucleus of the stria terminalis (BNST). This brain region contains CRF receptors that drive drug-seeking behavior exacerbated by stress. We used electron microscopy to quantitatively compare immunolabeling of the corticotropin-releasing factor receptor (CRFr) and CRF in the anterolateral bed nucleus of the stria terminalis (BSTal) of mice injected with saline or morphine in escalating doses for 14 days. We also compared the results with those in non-injected control mice. The tissue was processed for CRFr immunogold and CRF immunoperoxidase labeling. The non-injected controls had a significantly lower plasmalemmal density of CRFr immunogold particles in dendrites compared with mice receiving saline, but not those receiving morphine, injections. Compared with saline, however, mice receiving chronic morphine showed a significantly lower plasmalemmal, and greater cytoplasmic, density of CRFr immunogold in dendrites. Within the cytoplasmic compartment of somata and dendrites of the BSTal, the proportion of CRFr gold particles associated with mitochondria was three times as great in mice receiving morphine compared with saline. This subcellular distribution is consistent with morphine,- and CRFr-associated modulation of intracellular calcium release or oxidative stress. The between-group changes occurred without effect on the total number of dendritic CRFr immunogold particles, suggesting that chronic morphine enhances internalization or decreases delivery of the CRFr to the plasma membrane, a trafficking effect that is also affected by the stress of daily injections. In contrast, saline and morphine treatment groups showed no significant differences in the total number of CRF-immunoreactive axon terminals, or the frequency with which these terminals contacted CRFr-containing dendrites. This suggests that morphine does not influence axonal availability of CRF in the BSTal. The results have important implications for drug-associated adaptations in brain stress systems that may contribute to the motivation to continue drug use during dependence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19539724      PMCID: PMC2740727          DOI: 10.1016/j.neuroscience.2009.06.029

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  93 in total

Review 1.  Diversity and dynamics of dendritic signaling.

Authors:  M Häusser; N Spruston; G J Stuart
Journal:  Science       Date:  2000-10-27       Impact factor: 47.728

2.  Agonist-induced internalization of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus.

Authors:  Beverly A S Reyes; Krysta Fox; Rita J Valentino; Elisabeth J Van Bockstaele
Journal:  Eur J Neurosci       Date:  2006-06       Impact factor: 3.386

Review 3.  New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata.

Authors:  G F Alheid; L Heimer
Journal:  Neuroscience       Date:  1988-10       Impact factor: 3.590

4.  Differential regulation of corticotropin-releasing factor and vasopressin in discrete brain regions after morphine administration: correlations with hypothalamic noradrenergic activity and pituitary-adrenal response.

Authors:  M V Milanés; M L Laorden; M Chapleur-Château; A Burlet
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1997-11       Impact factor: 3.000

5.  A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking.

Authors:  S Erb; J Stewart
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

6.  Influence of acute and chronic morphine or stadol on the secretion of adrenocorticotrophin and its hypothalamic releasing hormone in the rat.

Authors:  E S el Daly
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

7.  Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine.

Authors:  J C Buckingham; T A Cooper
Journal:  Neuroendocrinology       Date:  1984-05       Impact factor: 4.914

8.  Dendritic distributions of dopamine D1 receptors in the rat nucleus accumbens are synergistically affected by startle-evoking auditory stimulation and apomorphine.

Authors:  Y Hara; V M Pickel
Journal:  Neuroscience       Date:  2007-05-09       Impact factor: 3.590

Review 9.  A role for brain stress systems in addiction.

Authors:  George F Koob
Journal:  Neuron       Date:  2008-07-10       Impact factor: 17.173

10.  Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization.

Authors:  Manuela Pfeiffer; Susanne Kirscht; Ralf Stumm; Thomas Koch; Daifei Wu; Magdalena Laugsch; Helmut Schröder; Volker Höllt; Stefan Schulz
Journal:  J Biol Chem       Date:  2003-10-07       Impact factor: 5.157

View more
  11 in total

1.  Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse.

Authors:  Beth A Costine; Joseph G Oberlander; Matthew C Davis; Carlos A A Penatti; Donna M Porter; Robert N Leaton; Leslie P Henderson
Journal:  Psychoneuroendocrinology       Date:  2010-05-26       Impact factor: 4.905

Review 2.  The mitochondrial component of intracrine action.

Authors:  Richard N Re; Julia L Cook
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-09       Impact factor: 4.733

3.  Enhanced dendritic availability of μ-opioid receptors in inhibitory neurons of the extended amygdala in mice deficient in the corticotropin-releasing factor-1 receptor.

Authors:  Azra Jaferi; Ping Zhou; Virginia M Pickel
Journal:  Synapse       Date:  2011-01       Impact factor: 2.562

Review 4.  Substance use modulates stress reactivity: Behavioral and physiological outcomes.

Authors:  Anne Q Fosnocht; Lisa A Briand
Journal:  Physiol Behav       Date:  2016-02-19

Review 5.  Functional Heterogeneity in the Bed Nucleus of the Stria Terminalis.

Authors:  Nur Zeynep Gungor; Denis Paré
Journal:  J Neurosci       Date:  2016-08-03       Impact factor: 6.167

6.  β-Adrenergic receptors enhance excitatory transmission in the bed nucleus of the stria terminalis through a corticotrophin-releasing factor receptor-dependent and cocaine-regulated mechanism.

Authors:  William P Nobis; Thomas L Kash; Yuval Silberman; Danny G Winder
Journal:  Biol Psychiatry       Date:  2011-02-21       Impact factor: 13.382

Review 7.  Corticotropin releasing factor and norepinephrine related circuitry changes in the bed nucleus of the stria terminalis in stress and alcohol and substance use disorders.

Authors:  Angela E Snyder; Yuval Silberman
Journal:  Neuropharmacology       Date:  2021-10-06       Impact factor: 5.250

Review 8.  Using high resolution imaging to determine trafficking of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus.

Authors:  B A S Reyes; D A Bangasser; R J Valentino; E J Van Bockstaele
Journal:  Life Sci       Date:  2014-07-21       Impact factor: 5.037

9.  Emerging role for corticotropin releasing factor signaling in the bed nucleus of the stria terminalis at the intersection of stress and reward.

Authors:  Yuval Silberman; Danny G Winder
Journal:  Front Psychiatry       Date:  2013-05-29       Impact factor: 4.157

10.  Corticotropin-Releasing Factor Receptors Modulate Oxytocin Release in the Dorsolateral Bed Nucleus of the Stria Terminalis (BNST) in Male Rats.

Authors:  Daisy Martinon; Joanna Dabrowska
Journal:  Front Neurosci       Date:  2018-03-21       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.